2004
DOI: 10.1016/j.bcp.2004.05.008
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
79
0
1

Year Published

2007
2007
2023
2023

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 128 publications
(85 citation statements)
references
References 24 publications
3
79
0
1
Order By: Relevance
“…PIC is a metabolite of RES (Fig. 1), and differs from its parent compound due to the extra hydroxyl group on the 3'-position of phenyl ring B [38][39][40]. In the present analysis, RAW 264.7 macrophages demonstrated greatest sensitivity to PIC.…”
Section: Discussionmentioning
confidence: 60%
“…PIC is a metabolite of RES (Fig. 1), and differs from its parent compound due to the extra hydroxyl group on the 3'-position of phenyl ring B [38][39][40]. In the present analysis, RAW 264.7 macrophages demonstrated greatest sensitivity to PIC.…”
Section: Discussionmentioning
confidence: 60%
“…Several studies have shown, using human liver microsomes or monitoring metabolites in vivo in pharmacokinetic studies, that hydroxylation can occur at various positions on lignans, isoflavones, and other flavonoids, producing an array of novel secondary oxidation products [18][19][20][21][22]. However, oxidation products appear to be minor metabolites of most polyphenols, probably due to rapid conjugation of the would-be Phase I substrates in the intestinal epithelium and the liver.…”
Section: Sources Of Variation In Phytochemical Metabolism and Disposimentioning
confidence: 99%
“…It was found that resveratrol is metabolized to piceatannol in the reaction of hydroxylation catalyzed by CYP1A2 (Piver et al 2004) and CYP1B1 (Potter et al 2002). Poor bioavailability of resveratrol caused by its fast metabolism to glucuronides and sulphates limits the use of this stilbene as a potent chemopreventive / chemotherapeutic agent (Walle et al, 2004).…”
Section: Trans-resveratrolmentioning
confidence: 99%
“…The major metabolite M2 has been identified as piceatannol (3,4,3',5'-tetrahydroxystilbene), while 3,4,5,4'-tetrahydroxystilbene was proposed as the M1 product. More recent work (Piver et al, 2004) provided evidence that CYP1A2 is also engaged in the metabolism of transresveratrol to piceatannol and tetrahydroxystilbene M1. Our studies confirmed the possibility of two pathways of metabolism on the grounds of molecular docking analysis.…”
mentioning
confidence: 99%